His primary scientific interests are in Virology, Immunology, Hepatitis C virus, Virus and Vaccination. His Virology research incorporates elements of Liver disease and Immunity. His study in Antibody, Immunogenicity, Immune system, Hepatitis B and Viral load falls under the purview of Immunology.
The concepts of his Hepatitis C virus study are interwoven with issues in Viral disease and Hepatitis C. His studies in Virus integrate themes in fields like Cell culture and Molecular biology. His research in Vaccination intersects with topics in Booster dose and Hepatitis B vaccine.
His primary areas of study are Immunology, Virology, Immunogenicity, Antibody and Vaccination. His Immunology study frequently draws connections to other fields, such as Internal medicine. His research is interdisciplinary, bridging the disciplines of Immunity and Virology.
He interconnects Booster dose, Tolerability, Clinical trial and Randomized controlled trial in the investigation of issues within Immunogenicity. The Antibody study combines topics in areas such as Plasmodium falciparum and In vivo. Geert Leroux-Roels has researched Vaccination in several fields, including Cellular immunity, Seroconversion, Adverse effect and Immunization.
Geert Leroux-Roels mainly focuses on Immunology, Virology, Immunogenicity, Vaccination and Antibody. His Immunology research is multidisciplinary, incorporating perspectives in Human liver and Internal medicine. His study involves Hepatitis C virus and Virus, a branch of Virology.
His work on Reactogenicity as part of general Immunogenicity research is frequently linked to Double blind, thereby connecting diverse disciplines of science. He has included themes like Hepatitis B vaccine, Immunization and Antibody titer in his Vaccination study. His Antibody study integrates concerns from other disciplines, such as Chloroquine, Malaria, Malaria vaccine and Immunity.
His primary areas of study are Immunology, Virology, Vaccination, Antibody and In vivo. His research investigates the connection with Immunology and areas like Internal medicine which intersect with concerns in Vaccine efficacy. His Virology study typically links adjacent topics like Deep sequencing.
His studies deal with areas such as Poliovirus, Poliomyelitis and Antigen, Immunogenicity as well as Vaccination. His research in Antibody tackles topics such as Immunity which are related to areas like Chloroquine and Acquired immune system. His work carried out in the field of Hepatitis C virus brings together such families of science as Liver disease and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.
Isabel Leroux-Roels;Astrid Borkowski;Thomas Vanwolleghem;Mamadou Dramé.
The Lancet (2007)
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
Brett D. Lindenbach;Philip Meuleman;Alexander Ploss;Thomas Vanwolleghem.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Philip Meuleman;Louis Libbrecht;Rita De Vos;Bernard de Hemptinne.
Hepatology (2005)
Unmet needs in modern vaccinology: Adjuvants to improve the immune response
Geert Leroux-Roels.
Vaccine (2010)
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
Philip Meuleman;Joseph Hesselgesser;Matthew Paulson;Thomas Vanwolleghem.
Hepatology (2008)
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Pierre Vandepapelière;Yves Horsmans;Philippe Moris;Marcelle Van Mechelen.
Vaccine (2008)
Line Probe Assay for Monitoring Drug Resistance in Hepatitis B Virus-Infected Patients during Antiviral Therapy
Lieven Stuyver;Caroline Van Geyt;Sija De Gendt;Georges Van Reybroeck.
Journal of Clinical Microbiology (2000)
Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations
Hélène Quach;Maxime Rotival;Maxime Rotival;Julien Pothlichet;Julien Pothlichet;Yong-Hwee Eddie Loh;Yong-Hwee Eddie Loh.
Cell (2016)
Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant
Artur Kaul;Ilka Woerz;Philip Meuleman;Geert Leroux-Roels.
Journal of Virology (2007)
Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
Michael P. Cooreman;Geert Leroux-Roels;Wilma P. Paulij.
Journal of Biomedical Science (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ghent University
Ghent University
University of Antwerp
University of Copenhagen
University of Strasbourg
KU Leuven
Schering-Plough
Radboud University Nijmegen
University of Naples Federico II
Inserm : Institut national de la santé et de la recherche médicale
Kyung Hee University
Queensland University of Technology
The University of Texas at Dallas
Uppsala University
ETH Zurich
Xiamen University
University of Rostock
State University of Campinas
Vrije Universiteit Amsterdam
Johns Hopkins University School of Medicine
Hebrew University of Jerusalem
Purdue University West Lafayette
Agricultural Research Organization
Mayo Clinic
University of California, San Francisco
Bielefeld University